Literature DB >> 12393431

Regulation of Akt-dependent cell survival by Syk and Rac.

Kun Jiang1, Bin Zhong, Connie Ritchey, Danielle L Gilvary, Elizabeth Hong-Geller, Sheng Wei, Julie Y Djeu.   

Abstract

Interleukin-2 (IL-2) prevents cell apoptosis and promotes survival, but the involved mechanisms have not been completely defined. Although phosphatidylinositide 3-kinase (PI 3-kinase) has been implicated in IL-2-mediated survival mechanisms, none of the 3 chains of the IL-2 receptor (IL-2R) expresses a binding site for PI 3-kinase. However, IL-2Rbeta does express a Syk-binding motif. By using an IL-2-dependent natural killer (NK) cell line, followed by validation of the results in fresh human NK cells, we identified Syk as a critical effector essential for IL-2-mediated prosurvival signaling in NK cells. Down-regulation of Syk by piceatannol treatment impaired NK cellular viability and induced prominent apoptosis as effectively as suppression of PI 3-kinase function by LY294002. Expression of kinase-deficient Syk or pretreatment with piceatannol markedly suppressed IL-2-stimulated activation of PI 3-kinase and Akt, demonstrating that Syk is upstream of PI 3-kinase and Akt. However, constitutively active PI 3-kinase reversed this loss of Akt function caused by kinase-deficient Syk or piceatannol. Thus, Syk appears to regulate PI 3-kinase, which controls Akt activity during IL-2 stimulation. More important, we observed Rac1 activation by IL-2 and found that it mediated PI 3-kinase activation of Akt. This conclusion came from experiments in which dominant-negative Rac1 significantly decreased IL-2-induced Akt activation, whereas constitutively active Rac1 reelevated Akt activity not only in Syk-impaired but also in PI 3-kinase-impaired NK cells. These results constitute the first report of a Syk --> PI3K --> Rac1 --> Akt signal cascade controlled by IL-2 that mediates NK cell survival.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12393431     DOI: 10.1182/blood-2002-04-1251

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  21 in total

1.  Inhibition of lymphocyte activation and function by the prenylation inhibitor L-778,123.

Authors:  Ming-Sing Si; Bruce A Reitz; Dominic C Borie
Journal:  Invest New Drugs       Date:  2005-01       Impact factor: 3.850

2.  Distribution of small Rho GTPases in the developing rat submandibular gland.

Authors:  Virgínia O Crema; Anna Christina M Fossati; Dânia E Hamassaki; Marinilce F Santos
Journal:  J Mol Histol       Date:  2008-09-11       Impact factor: 2.611

3.  GPCR48/LGR4 promotes tumorigenesis of prostate cancer via PI3K/Akt signaling pathway.

Authors:  Fang Liang; Junmin Yue; Junyong Wang; Lijuan Zhang; Rui Fan; Hao Zhang; Qingsong Zhang
Journal:  Med Oncol       Date:  2015-01-31       Impact factor: 3.064

Review 4.  Hematopoietic-specific Rho GTPases Rac2 and RhoH and human blood disorders.

Authors:  Anja Troeger; David A Williams
Journal:  Exp Cell Res       Date:  2013-07-11       Impact factor: 3.905

5.  Infectious angiogenesis: Bartonella bacilliformis infection results in endothelial production of angiopoetin-2 and epidermal production of vascular endothelial growth factor.

Authors:  Francesca Cerimele; Lawrence F Brown; Francisco Bravo; Garret M Ihler; Philomene Kouadio; Jack L Arbiser
Journal:  Am J Pathol       Date:  2003-10       Impact factor: 4.307

6.  Tumor necrosis factor-like weak inducer of apoptosis stimulation of glioma cell survival is dependent on Akt2 function.

Authors:  Shannon P Fortin; Matthew J Ennis; Benjamin A Savitch; David Carpentieri; Wendy S McDonough; Jeffrey A Winkles; Joseph C Loftus; Christopher Kingsley; Galen Hostetter; Nhan L Tran
Journal:  Mol Cancer Res       Date:  2009-10-27       Impact factor: 5.852

7.  Enhanced NK-cell development and function in BCAP-deficient mice.

Authors:  Alexander W MacFarlane; Tetsuo Yamazaki; Min Fang; Luis J Sigal; Tomohiro Kurosaki; Kerry S Campbell
Journal:  Blood       Date:  2008-03-12       Impact factor: 22.113

8.  Rac1 inhibits apoptosis in human lymphoma cells by stimulating Bad phosphorylation on Ser-75.

Authors:  Baolin Zhang; Yaqin Zhang; Emily Shacter
Journal:  Mol Cell Biol       Date:  2004-07       Impact factor: 4.272

9.  Inositol tetrakisphosphate limits NK cell effector functions by controlling PI3K signaling.

Authors:  Karsten Sauer; Eugene Park; Sabine Siegemund; Anthony R French; Joseph A Wahle; Luise Sternberg; Stephanie Rigaud; A Helena Jonsson; Wayne M Yokoyama; Yina H Huang
Journal:  Blood       Date:  2012-11-21       Impact factor: 22.113

10.  Dominant role of antigen dose in CD4+Foxp3+ regulatory T cell induction and expansion.

Authors:  Michael S Turner; Lawrence P Kane; Penelope A Morel
Journal:  J Immunol       Date:  2009-10-15       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.